Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
life sciences
national blog main
new york blog main
4
×
new york top stories
san francisco blog main
san francisco top stories
satsuma pharmaceuticals
4
×
dihydroergotamine
glaxosmithkline
raleigh-durham blog main
raleigh-durham top stories
springworks therapeutics
10x genomics
abbvie
bausch health
biogen
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
deals
detroit blog main
detroit top stories
eli lilly
gene therapy
generic drugs
indiana blog main
indiana top stories
johnson & johnson
medical device
migraine
multiple myeloma
national
national top stories
nirogacestat
novartis
pfizer
What
biotech
companies
bio
days
drug
ipo
news
roundup
satsuma
springworks
activity
approval
august
biogen’s
biopharmaceutical
boost
busy
convo
decisions
devices
dog
drugs
earlier
failures
fda
firm
followed
genomics
hasn’t
haul
ipos
leading
led
legacy
life
line
littered
markets
migraine
nash
Language
unset
Current search:
" satsuma pharmaceuticals "
×
" new york blog main "
×
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More